AP NEWS

Constipation Pipeline Review, H2 2018 - Therapeutic Assessment of 17 Companies & Drug Profiles - ResearchAndMarkets.com

September 25, 2018

DUBLIN--(BUSINESS WIRE)--Sep 25, 2018--The “Constipation - Pipeline Review, H2 2018” drug pipelines has been added to ResearchAndMarkets.com’s offering.

Constipation - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Constipation (Gastrointestinal), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Constipation (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Constipation and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, Preclinical and Discovery stages are 4, 4, 8, 2, 2 and 1 respectively. Similarly, the Universities portfolio in Discovery stages comprises 1 molecules, respectively.

Constipation (Gastrointestinal) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Key Topics Covered:

Introduction Report Coverage Constipation - Overview Constipation - Therapeutics Development Pipeline Overview Pipeline by Companies Pipeline by Universities/Institutes Products under Development by Companies Products under Development by Universities/Institutes Constipation - Therapeutics Assessment Assessment by Target Assessment by Mechanism of Action Assessment by Route of Administration Assessment by Molecule Type Constipation - Companies Involved in Therapeutics Development Allergan Plc Ardelyx Inc Braintree Laboratories Inc Dong-A ST Co Ltd EA Pharma Co Ltd Ironwood Pharmaceuticals Inc Johnson & Johnson MallInckrodt Plc NGM Biopharmaceuticals Inc RaQualia Pharma Inc Sanwa Kagaku Kenkyusho Co Ltd SK Biopharmaceuticals Co Ltd Sumitomo Dainippon Pharma Co Ltd Synthetic Biologics Inc Vanda Pharmaceuticals Inc Yuhan Corp Zensun (Shanghai) Sci & Tech Co Ltd For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/73czxj/constipation?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180925006193/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Gastrointestinal Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH CLINICAL TRIALS PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 09/25/2018 05:02 PM/DISC: 09/25/2018 05:02 PM

http://www.businesswire.com/news/home/20180925006193/en

AP RADIO
Update hourly